Global Radiotherapy Market to reach USD 13.1 billion by 2026.

Global Radiotherapy Market Size study, by Type (External beam radiation therapy, Internal radiation therapy and Systemic radiation therapy), Application (skin & lip cancer, breast Cancer, head & neck cancer, prostate cancer, cervical cancer, spine cancer, lung cancer and others) End-user (hospitals, cancer research institutes and ambulatory & radiotherapy centers) and Regional Forecasts 2019-2026
Product Code:  HALDAT_85700240
TABLE OF CONTENTS
Chapter 1.	 Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Radiotherapy Market, by Type, 2016-2026 (USD Billion)
1.3.2.	Radiotherapy Market, by Application, 2016-2026 (USD Billion)
1.3.3.	Radiotherapy Market, by End-user, 2016-2026 (USD Billion)
1.3.4.	Radiotherapy Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Radiotherapy Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Radiotherapy Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Radiotherapy Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Radiotherapy Market, By Type 
5.1.	Market Snapshot 
5.1.	Market Performance - Potential Model
5.2.	Global Radiotherapy Market, Sub Segment Analysis
5.2.1.	     External Beam Radiation Therapy 
5.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.2.	     Internal Radiation Therapy 
5.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.2.3.	  Systemic Radiation Therapy 
5.2.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.2.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Global Radiotherapy Market, By Application 
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Global Radiotherapy Market, Sub Segment Analysis
6.3.1.	    Skin & Lip Cancer 
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	  Breast Cancer 
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.3.	 Head & Neck Cancer   
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.	 Prostate Cancer 
6.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.5.	 Cervical Cancer 
6.3.5.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.6.	 Spine Cancer 
6.3.6.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.6.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.7.	Lung Cancer 
6.3.7.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.7.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
6.3.8.	 Others 
6.3.8.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.8.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
Chapter 7.	Global Radiotherapy Market, By End-users  
7.1.	Market Snapshot 
7.2.	Market Performance - Potential Model
7.3.	Global Radiotherapy Market, Sub Segment Analysis
7.3.1.	     Hospitals 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.	  Cancer Research Institutes 
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.3.3.	 Ambulatory & Radiotherapy Centres 
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8.	Global Radiotherapy Market, by Regional Analysis
8.1.	Radiotherapy Market, Regional Market Snapshot (2016-2026)
8.2.	North America Radiotherapy Market Snapshot
8.2.1.	U.S.
8.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.2.	 Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.2.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.	Canada
8.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.2.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.	Europe Radiotherapy Market Snapshot
8.3.1.	U.K. 
8.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.3.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.	Germany 
8.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.3.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.5.	Billion)
8.3.3.	Rest of Europe
8.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.3.3.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.	Asia Radiotherapy Market Snapshot
8.4.1.	China 
8.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.4.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.	India 
8.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.4.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.	Japan
8.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.4.3.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.	Rest of Asia Pacific
8.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.4.4.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

8.5.	Latin America Radiotherapy Market Snapshot
8.5.1.	Brazil 
8.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.5.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.5.	Billion)

8.5.2.	Mexico 
8.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.5.2.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.	Rest of The World 
8.6.1.	Middle East and Africa
8.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion
8.6.1.3.	Application breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.4.	End-user breakdown estimates & forecasts, 2016-2026 (USD Billion)

Chapter 9.	Competitive Intelligence
9.1.	Company Market Share (Subject to Data Availability)
9.2.	Top Market Strategies
9.3.	Company Profiles
9.3.1.	  GE Healthcare
9.3.1.1.	Overview
9.3.1.2.	Financial (Subject to Data Availability)
9.3.1.3.	Product Summary
9.3.1.4.	Recent Developments
9.3.2.	  Siemens AG
9.3.3.	Canon Medical Systems Corporation
9.3.4.	Varian Medical Systems, Inc.
9.3.5.	 Ion Beam Applications
9.3.6.	Nordion
9.3.7.	 Isoray
9.3.8.	Mirada Medical
9.3.9.	 Elekta AB
9.3.10.	 Varian Medical Systems Inc 
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.1.6.	Research Assumption

Global radiotherapy market is valued at approximately USD 7.7 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 6.90 % over the forecast period 2019-2026. Technological advancements in radiotherapy and increasing government investments to meet the demand for cancer treatment are some key trend triggering the growth of the radiotherapy market over the forecast period.
Key driving factor for the radiotherapy market is increasing prevalence of cancer. Since, radiotherapy tests allows clinicians to identify and detect organism accurately and helps to offer proper guidance to clinicians thereby, promoting the demand for radiotherapy tests over the forecast period. According to Cancer index, it was estimated that around 2,814,000 of Chinese would die from cancer in 2015 equivalent to around 7,500 cancer deaths every day on an average basis in the country. Similarly, as per the National Institute of Cancer Prevention and Research of India, 1 woman affected by cervical cancer dies due to its impact in every 8 minutes. For every 2 women newly diagnosed with breast cancer, 1women die. Every year, over 7 lakh cancer cases are registered in India which in turn causes 5,56,400 deaths in year that is fueling the adoption and utility of radiotherapy in India. Also, as per the National Cancer Control Strategy (2017-2022), Cancer is estimated to be the 3rd leading cause of death after cardiovascular diseases and infectious diseases in Middle East & Africa region. Thus, high prevalence of cancer would increase the need for radiotherapy treatment as it is beneficial to treat cancer, promoting the growth of the radiotherapy market. Furthermore, growing awareness about the advantages of radiotherapy along with the use of particle therapy for cancer treatment offers lucrative growth prospects for the Radiotherapy market. However, lack of trained personnel expected to hinder the growth of the market during the forecast period.

On the basis of segmentation, the radiotherapy market is segmented into type, application and end-user. Type segment of global radiotherapy market is classified into external beam radiation therapy, internal radiation therapy and systemic radiation therapy of which external beam radiotherapy segment is expected to grow at a highest CAGR owing to the increases accuracy and precision of tumor targeting. On the basis of application segment, the market is diversified into skin & lip cancer, breast cancer, head & neck cancer, prostate cancer, cervical cancer, spine cancer, lung cancer and others. The end-user segment is classified into hospitals, cancer research institutes and ambulatory & radiotherapy centers of which hospital segment is anticipated to witness lucrative growth owing to the increasing installation of advanced radiotherapy equipment along with government initiatives and funding to promote the adoption of advanced cancer treatment technologies.

The regional analysis of radiotherapy market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in radiotherapy market owing to the increasing number of cancer cases coupled with the technological advancements in radiotherapy equipment. Also, the dominance of North America region is witnessed owing to the presence of market players such as GE Healthcare, Varian Medical Systems, Inc and others. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific region is witnessed owing to high prevalence of cancer along with rising geriatric population. Also, improving healthcare infrastructure and services in rural areas is also expected to supplement the growth of Asia-Pacific region over the forecast period.
The leading market players include-

GE Healthcare
Siemens AG
Canon Medical Systems Corporation
Varian Medical Systems, Inc.
Ion Beam Applications
Nordion
Isoray
Mirada Medical
Elekta AB
Varian Medical Systems Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiation Therapy
By Application:
Skin & Lip Cancer
Breast Cancer
Head & Neck Cancer
Prostate Cancer
Cervical Cancer
Spine Cancer
Lung Cancer
Others
By End-user:
Hospitals
Cancer Research Institutes
Ambulatory & Radiotherapy Centers

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
ROE
Asia Pacific
China
India
Japan
ROAPEC
LAMEA
Brazil
Mexico
ROW
Middle East & Africa

Furthermore, years considered for the study are as follows:
Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Radiotherapy Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…